RP Management, LLC
CIK
1507673
Location
New York, NY
Portfolio Value
Small
$138,841,737
Diversification
Highly concentrated
Filing Date
Global Rank
#4,553
/ 7,987
▼ 487
· as of Mar 2025
Top Industry
Biotechnology
79.2%
3Y Alpha vs SPY
-10.4%
Period ended 1 year ago
Filed May 2, 2025 · 1y
19 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+38.9%
SPY
+76.0%
Annualised alpha
-9.1%
Max drawdown
−61.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Mar 31, 2025 · Δ vs Dec 31, 2024Top Position
50.8%
−8.5 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
3,822
Highly concentrated−572
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $138,841,737 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
3 positions ·
$138,841,737 total
· as of Mar 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 2,936,507 | $70,593,628 | 50.84% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 980,392 | $39,401,954 | 28.38% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Held | 3,846,154 | $28,846,155 | 20.78% |